Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: effects of methoxsalen, a CYP2A5/6 inhibitor.

Alsharari SD, Siu EC, Tyndale RF, Damaj MI.

Nicotine Tob Res. 2014 Jan;16(1):18-25. doi: 10.1093/ntr/ntt105. Epub 2013 Jul 24.

2.

The Value of Performance Measurement in Promoting Improvements in Women's Health.

Siu EC, Levinton C, Brown AD.

Healthc Policy. 2009 Nov;5(2):52-67.

3.

Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine.

Grieder TE, Sellings LH, Vargas-Perez H, Ting-A-Kee R, Siu EC, Tyndale RF, van der Kooy D.

Neuropsychopharmacology. 2010 Mar;35(4):943-54. doi: 10.1038/npp.2009.198. Epub 2009 Dec 23.

4.

Interactions between age and the aversive effects of nicotine withdrawal under mecamylamine-precipitated and spontaneous conditions in male Wistar rats.

Shram MJ, Siu EC, Li Z, Tyndale RF, LĂȘ AD.

Psychopharmacology (Berl). 2008 Jun;198(2):181-90. doi: 10.1007/s00213-008-1115-x. Epub 2008 Apr 3.

PMID:
18385986
5.

Selegiline is a mechanism-based inactivator of CYP2A6 inhibiting nicotine metabolism in humans and mice.

Siu EC, Tyndale RF.

J Pharmacol Exp Ther. 2008 Mar;324(3):992-9. Epub 2007 Dec 7.

PMID:
18065502
6.

Non-nicotinic therapies for smoking cessation.

Siu EC, Tyndale RF.

Annu Rev Pharmacol Toxicol. 2007;47:541-64. Review.

PMID:
17209799
7.

Characterization and comparison of nicotine and cotinine metabolism in vitro and in vivo in DBA/2 and C57BL/6 mice.

Siu EC, Tyndale RF.

Mol Pharmacol. 2007 Mar;71(3):826-34. Epub 2006 Dec 7.

PMID:
17158199
8.

Inhibition of nicotine metabolism by methoxysalen: Pharmacokinetic and pharmacological studies in mice.

Damaj MI, Siu EC, Sellers EM, Tyndale RF, Martin BR.

J Pharmacol Exp Ther. 2007 Jan;320(1):250-7. Epub 2006 Oct 4.

PMID:
17021260
9.

Nicotine self-administration in mice is associated with rates of nicotine inactivation by CYP2A5.

Siu EC, Wildenauer DB, Tyndale RF.

Psychopharmacology (Berl). 2006 Mar;184(3-4):401-8. Epub 2006 Jan 28.

PMID:
16485141

Supplemental Content

Support Center